BALANOL ANALOGUES

Lars Ole Lyngsø (Inventor), John Nielsen (Inventor)

    Research output: PatentResearch

    Abstract

    The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.
    Original languageEnglish
    Patent numberWO1997029091
    Filing date14/08/1997
    CountryInternational Bureau of the World Intellectual Property Organization (WIPO)
    Publication statusPublished - 1997

    Bibliographical note

    49 pages

    Cite this

    Lyngsø, L. O., & Nielsen, J. (1997). BALANOL ANALOGUES. (Patent No. WO1997029091).
    Lyngsø, Lars Ole (Inventor) ; Nielsen, John (Inventor). / BALANOL ANALOGUES. Patent No.: WO1997029091. Aug 14, 1997.
    @misc{aa0f466214794eeab96ea0f47bb6e2d5,
    title = "BALANOL ANALOGUES",
    abstract = "The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.",
    author = "Lyngs{\o}, {Lars Ole} and John Nielsen",
    note = "49 pages; WO1997029091",
    year = "1997",
    language = "English",
    type = "Patent",

    }

    Lyngsø, LO & Nielsen, J Aug. 14 1997, BALANOL ANALOGUES, Patent No. WO1997029091.

    BALANOL ANALOGUES. / Lyngsø, Lars Ole (Inventor); Nielsen, John (Inventor).

    Patent No.: WO1997029091. Aug 14, 1997.

    Research output: PatentResearch

    TY - PAT

    T1 - BALANOL ANALOGUES

    AU - Lyngsø, Lars Ole

    AU - Nielsen, John

    N1 - 49 pages

    PY - 1997

    Y1 - 1997

    N2 - The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.

    AB - The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.

    M3 - Patent

    M1 - WO1997029091

    Y2 - 1997/08/14

    ER -

    Lyngsø LO, Nielsen J, inventors. BALANOL ANALOGUES. WO1997029091. 1997.